Effect of donor non-muscle myosin heavy chain (MYH9) gene polymorphisms on clinically relevant kidney allograft dysfunction.


Journal

BMC nephrology
ISSN: 1471-2369
Titre abrégé: BMC Nephrol
Pays: England
ID NLM: 100967793

Informations de publication

Date de publication:
01 09 2020
Historique:
received: 21 03 2020
accepted: 23 08 2020
entrez: 3 9 2020
pubmed: 3 9 2020
medline: 21 10 2021
Statut: epublish

Résumé

Despite its established association with chronic kidney disease (CKD) the role of myosin-9 (MYH9) gene variation on transplanted kidney function remains unknown. This study aimed at evaluating the effect of donor MYH9 nephrogenic variants on renal allograft function within the first post transplantation year. In the longitudinal kidney transplant study 207 deceased donors were genotyped for previously known risk MYH9 single nucleotide polymorphisms (SNPs). The predictor was MYH9 high-risk variants status. The primary outcome was mean eGFR found in low vs. high risk MYH9 genotypes between third and twelfth post-transplant month, the secondary outcome was the risk of proteinuria. Distribution of genotypes remained in Hardy-Weinberg equilibrium. The T allele of rs3752462 (dominant model, TT or TC vs. CC) was associated with higher filtration rate (P = 0.05) in a multivariate analysis after adjusting for delayed graft function and donor sex. Two G alleles of rs136211 (recessive model, GG vs. GA or AA) resulted in doubling the risk of proteinuria (OR = 2.22; 95% CI = 1.18-4.37, P = 0.017) after adjusting for donor and recipient sex. Deceased donor kidneys of European descent harboring MYH9 SNPs rs3752462 T allele show significantly superior estimated filtration rate while those of rs136211 GG genotype excessive risk of proteinuria. These findings, if replicated, may further inform and improve individualization of allocation and treatment policies.

Sections du résumé

BACKGROUND
Despite its established association with chronic kidney disease (CKD) the role of myosin-9 (MYH9) gene variation on transplanted kidney function remains unknown. This study aimed at evaluating the effect of donor MYH9 nephrogenic variants on renal allograft function within the first post transplantation year.
METHODS
In the longitudinal kidney transplant study 207 deceased donors were genotyped for previously known risk MYH9 single nucleotide polymorphisms (SNPs). The predictor was MYH9 high-risk variants status. The primary outcome was mean eGFR found in low vs. high risk MYH9 genotypes between third and twelfth post-transplant month, the secondary outcome was the risk of proteinuria.
RESULTS
Distribution of genotypes remained in Hardy-Weinberg equilibrium. The T allele of rs3752462 (dominant model, TT or TC vs. CC) was associated with higher filtration rate (P = 0.05) in a multivariate analysis after adjusting for delayed graft function and donor sex. Two G alleles of rs136211 (recessive model, GG vs. GA or AA) resulted in doubling the risk of proteinuria (OR = 2.22; 95% CI = 1.18-4.37, P = 0.017) after adjusting for donor and recipient sex.
CONCLUSION
Deceased donor kidneys of European descent harboring MYH9 SNPs rs3752462 T allele show significantly superior estimated filtration rate while those of rs136211 GG genotype excessive risk of proteinuria. These findings, if replicated, may further inform and improve individualization of allocation and treatment policies.

Identifiants

pubmed: 32873246
doi: 10.1186/s12882-020-02039-6
pii: 10.1186/s12882-020-02039-6
pmc: PMC7465840
doi:

Substances chimiques

MYH9 protein, human 0
Myosin Heavy Chains EC 3.6.4.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

380

Subventions

Organisme : Ministerstwo Nauki i Szkolnictwa Wyższego
ID : NN402426633, NN402566850
Pays : International

Références

Clin Transplant. 2015 Jul;29(7):644-53
pubmed: 25893485
Mol Med. 2011;17(11-12):1196-203
pubmed: 21792479
PLoS Genet. 2015 Sep 17;11(9):e1005459
pubmed: 26379250
Trends Cell Biol. 2007 Sep;17(9):428-37
pubmed: 17804239
J Am Soc Nephrol. 2002 Jan;13(1):65-74
pubmed: 11752022
Nat Rev Mol Cell Biol. 2009 Nov;10(11):778-90
pubmed: 19851336
J Diabetes Res. 2018 May 9;2018:5068578
pubmed: 29862302
J Am Soc Nephrol. 2017 Aug;28(8):2498-2510
pubmed: 28270413
Genes Immun. 2012 Apr;13(3):232-8
pubmed: 22189356
Clin Nephrol. 2003 Dec;60(6):440-1
pubmed: 14690266
Genet Mol Res. 2015 Feb 06;14(1):1008-16
pubmed: 25730040
Kidney Blood Press Res. 2016;41(6):956-965
pubmed: 27924804
Cytoskeleton (Hoboken). 2016 Aug;73(8):377-95
pubmed: 27232264
Nephrol Dial Transplant. 2011 Aug;26(8):2544-9
pubmed: 21245129
Front Mol Neurosci. 2017 Mar 14;10:75
pubmed: 28352215
Nefrologia. 2011;31(4):404-14
pubmed: 21738244
Hum Mol Genet. 2011 Jun 15;20(12):2450-6
pubmed: 21429915
Clin Nephrol. 1991 Jun;35(6):255-62
pubmed: 1873939
Int J Mol Med. 2006 May;17(5):729-36
pubmed: 16596254
Hum Mutat. 2014 Feb;35(2):236-47
pubmed: 24186861
Am J Transplant. 2009 Oct;9(10):2435-40
pubmed: 19764949
PLoS One. 2014 Mar 21;9(3):e87716
pubmed: 24658608
Clin Kidney J. 2014 Apr;7(2):107-14
pubmed: 25852857
Nat Genet. 2008 Oct;40(10):1175-84
pubmed: 18794856
Am J Transplant. 2008 Apr;8(4):753-60
pubmed: 18294345
Kidney Int. 2015 Feb;87(2):343-9
pubmed: 25229341
Med Hypotheses. 2013 Nov;81(5):908-10
pubmed: 24011553
Pharmacogenomics J. 2020 Aug;20(4):543-552
pubmed: 31902946
Nephrol Dial Transplant. 2013 Dec;28(12):2993-3003
pubmed: 24042022
Transplant Proc. 2016 Jun;48(5):1561-5
pubmed: 27496447
Kidney Int. 2010 Feb;77(4):299-311
pubmed: 19847156
J Dermatolog Treat. 2009;20(1):63-6
pubmed: 18629675
Nephrol Dial Transplant. 2012 Apr;27(4):1505-11
pubmed: 21968013
Gene. 2013 May 10;520(1):73-6
pubmed: 23470845
Ther Drug Monit. 2016 Apr;38 Suppl 1:S1-20
pubmed: 26977997
Am J Transplant. 2007 Dec;7(12):2748-56
pubmed: 17941956
Int J Cardiol. 2018 Nov 15;271:211-218
pubmed: 30144997
PLoS One. 2013;8(3):e57925
pubmed: 23516419
Transplantation. 2015 Oct;99(10):2038-48
pubmed: 26262502
Br J Haematol. 2011 Nov;155(3):386-94
pubmed: 21910715
Transl Res. 2018 Jul;197:1-11
pubmed: 29476712
Kidney Int. 2009 Aug;76(3):297-306
pubmed: 19387472
Kidney Int. 2010 Jul;78(2):207-14
pubmed: 20200500

Auteurs

Joanna Pazik (J)

Department of Transplantation Medicine, Nephrology and Internal Diseases, Medical University of Warsaw, 59 Nowogrodzka Street, 02-006, Warsaw, Poland. jt.pazik@gmail.com.

Monika Oldak (M)

Department of Histology and Embryology, Medical University of Warsaw, Warsaw, Poland.

Dominika Oziębło (D)

Department of Histology and Embryology, Medical University of Warsaw, Warsaw, Poland.
Postgraduate School of Molecular Medicine, Medical University of Warsaw, Warsaw, Poland.

Dominika Dęborska Materkowska (DD)

Department of Transplantation Medicine, Nephrology and Internal Diseases, Medical University of Warsaw, 59 Nowogrodzka Street, 02-006, Warsaw, Poland.

Anna Sadowska (A)

Department of Transplantation Medicine, Nephrology and Internal Diseases, Medical University of Warsaw, 59 Nowogrodzka Street, 02-006, Warsaw, Poland.

Jacek Malejczyk (J)

Department of Histology and Embryology, Medical University of Warsaw, Warsaw, Poland.

Magdalena Durlik (M)

Department of Transplantation Medicine, Nephrology and Internal Diseases, Medical University of Warsaw, 59 Nowogrodzka Street, 02-006, Warsaw, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH